Transocean Ltd vs Revvity Inc — how do they compare? Transocean Ltd trades at $5.57 (market cap $6.19B), while Revvity Inc trades at $152.05 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 2.7× Transocean Ltd's market cap, and Revvity Inc pays a 0.18% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Transocean Ltd for 18 Days and Revvity Inc for 12 Days on average.
| RIG | RVTY | |
|---|---|---|
Market Cap | $6.19B | $16.98B |
Volume | 30,564,415 | 1,456,900 |
Sector | Energy | Health |
52-Week High | $7.58 | $157.36 |
52-Week Low | $3.08 | $82.26 |
Typical Hold Time | 18 Days | 12 Days |
Enterprise Value | $10.80B | $19.30B |
Dividend Yield | — | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Transocean (RIG) trades at $5.39, down slightly by 0.19%, with a bearish technical signal from moving averages. The company reported a net loss of $2.92 billion in 2025, though revenue remains stable near $4 billion. Recent news highlights the $5.8 billion Valaris acquisition, approved by the DOJ, and new contracts like the $80 million deal for the Deepwater Conqueror, providing operational momentum amid a challenging profitability landscape.
The outlook is speculative, hinging on successful deleveraging and integration of the Valaris deal to improve cash flow. Key risks include high debt levels, execution challenges, and persistent negative margins. Analyst sentiment is mixed, with a 39% buy rating, reflecting cautious optimism tied to offshore cycle strength and debt reduction progress.
RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving average signals and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of a CE-IVDR-certified T1D screening kit in Europe (Business Wire, 2026-09-24) and the acquisition of Human Cell Design to expand metabolic disease research tools (Business Wire, 2026-09-09).
The outlook is positive, supported by earnings momentum, strategic acquisitions, and analyst optimism. However, the stock trades at a premium valuation with a P/E of 73.15, and near-term risks include margin pressures in China and rich valuation limiting upside beyond consensus targets. Revenue stability but slight profit margin compression in 2026 warrants monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →